School of Pharmacy - News

Collaboration will leverage University of Eastern Finland’s leading computational molecular simulation technology to identify novel therapeutic approaches and patient selection strategies as part of SpringWorks’ commitment to developing MAPK pathway targeted therapies.

The risks of an elective revascularisation procedure for coronary artery disease are similar for people with and without Alzheimer’s disease (AD), but people with AD have worse outcomes after an emergency procedure.

The funding will be used to promote research activities in areas of significance to the university, which pertain to drug development and discovery, neurosciences, the forest-based bioeconomy, and the development of technologies that make use of photonics. 

The University of Eastern Finland’s doctoral conferment ceremony at the Kuopio Campus is postponed to 9–11 June 2022 due to the coronavirus pandemic.

Jenny and Antti Wihuri Foundation has awarded Prasanthi Medarametla, PhD, with a grant of 70 000 euros for postdoctoral research.

MSc (Pharm) Jonna Tenhunen investigated the regulation of sirtuins in her doctoral thesis. Sirtuins are possible targets for drugs in many diseases such as cancer, neurological diseases, and metabolic disorders.

Selected to the Academy of Finland’s Flagship Programme for the years 2020–2024, the GeneCellNano Flagship seeks to speed up the introduction of new biological drugs for severe chronic diseases. The Flagship is led by Academy Professor Seppo Ylä-Herttuala.

The doctoral thesis of Jonna Weisell, MSc, provides novel information about the mechanisms underlying calcific aortic valve disease CAVD.